Oncotelic Therapeutics, Inc.

Over the past 90 days, Oncotelic Therapeutics (OTLC) has reported zero cyber incidents and zero red-flag 8-K filings related to bankruptcy, delisting, restatement, or officer departures. This clean recent window, however, reflects a limited observation period; absence of events in 90 days does not indicate absence of risk. The full $49 Report extends analysis across 12 months of SEC filings, calculates dilution risk scores from financing history, surfaces 8-K context and timing patterns, and applies AI-driven signals for emerging operational risk. The full $49 Report adds comprehensive dilution analysis, 12-month event history, and AI risk flagging to inform your investment decision.